AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Quaschning, T d'Uscio, LV Shaw, S Viswambharan, H Ruschitzka, FT Luscher, TF
Citation: T. Quaschning et al., Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension, NEPH DIAL T, 16(6), 2001, pp. 1176-1182

Authors: Spieker, LE Noll, G Ruschitzka, FT Luscher, TF
Citation: Le. Spieker et al., Endothelin receptor antagonists in congestive heart failure: A new therapeutic principle for the future?, J AM COL C, 37(6), 2001, pp. 1493-1505

Authors: Quaschning, T Corti, R Ruschitzka, FT Noll, C Luscher, TF
Citation: T. Quaschning et al., Vasopeptidase inhibitors: clinical implications of a new class of drugs, DEUT MED WO, 125(16), 2000, pp. 499-503

Authors: Spieker, LE Noll, G Ruschitzka, FT Maier, W Luscher, TF
Citation: Le. Spieker et al., Working under pressure: the vascular endothelium in arterial hypertension, J HUM HYPER, 14(10-11), 2000, pp. 617-630

Authors: Ruschitzka, FT Wenger, RH Stallmach, T Quaschning, T de Wit, C Wagner, K Labugger, R Kelm, M Noll, G Rulicke, T Shaw, S Lindberg, RLP Rodenwaldt, B Lutz, H Bauer, C Luscher, TF Gassmann, M
Citation: Ft. Ruschitzka et al., Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin, P NAS US, 97(21), 2000, pp. 11609-11613

Authors: Quaschning, T Ruschitzka, FT Maier, W Luscher, TF
Citation: T. Quaschning et al., The role of the endothelium in the development and treatment of vascular disease, INTERNIST, 41(4), 2000, pp. 355-362

Authors: Ruschitzka, FT Noll, G Luscher, TF
Citation: Ft. Ruschitzka et al., Calcium antagonists - Results of recent studies and their significance forpractice, INTERNIST, 40(2), 1999, pp. 225-234
Risultati: 1-7 |